An update on angiogenesis therapy

Critical Reviews in Eukaryotic Gene Expression

Volumn 11, Issue 1-3, 2001, Pages 1-21

  Davda, J ^a   Labhasetwar, V ^a  

^a 986025 Nebraska Medical Center ^*  (United States)

Author keywords

Drug delivery; Gene therapy; Growth factors; Ischemia

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 1; INTERLEUKIN 8; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROANGIOGENIC GROWTH FACTOR; PROLIFERIN; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ATHEROSCLEROSIS; CLINICAL TRIAL; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG SAFETY; GENE THERAPY; HEART MUSCLE ISCHEMIA; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT;

ANGIOPOIETIN-1; ANIMALS; ARTERIOSCLEROSIS; CHICK EMBRYO; CLINICAL TRIALS; COLLATERAL CIRCULATION; CORONARY ARTERIOSCLEROSIS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; DRUG EVALUATION, PRECLINICAL; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTORS; FORECASTING; GENE THERAPY; GROWTH SUBSTANCES; HINDLIMB; HUMANS; HYPOTENSION; ISCHEMIA; LYMPHOKINES; MEMBRANE GLYCOPROTEINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; RATS; RECEPTORS, GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034777694     PISSN: 10454403     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (141)

1. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo
2. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
3. Accelerated restitution of endothelial integrity and endotheliumdependent function after phVEGF165 gene transfer
4. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: Dose-response effect of basic fibroblast growth factor
5. Angiogenicinduced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs
6. Intracoronary injection of basic fibroblast growth factor enhances angiogenesis in infarcted swine myocardium
7. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia
8. Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor
9. Genentech enlightens other angiogenesis programs
10. The heparin-binding (fibroblast) growth factor family of proteins
11. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
12. Mechanisms of angiogenesis and arteriogenesis
13. Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
14. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
15. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis
16. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: Rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth
17. VEGF loaded microspheres injected intramuscularly produce local neovascularization in normal, aged C57BL-6 mice
18. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning
19. The angiopoietins: Yin and Yang in angiogenesis
20. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
21. Angiogenic attack as a therapeutic strategy for cancer
22. Overexpression of vascular permeability factor/vascular endothetial growth factor and its receptors in psoriasis
23. The fate of patients with critical leg ischemia
24. Vascular endothelial growth factor and diabetes: The agonist versus antagonist paradox
25. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
26. Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis
27. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
28. The role of vascular endothelial growth factor in pathological angiogenesis
29. Molecular and biological properties of vascular endothelial growth factor
30. Role of vascular endothelial growth factor in the regulation of angiogenesis
31. Clinical applications of angiogenic growth factors and their inhibitors
32. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
33. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells
34. Molecular and biological properties of the vascular endothelial growth factor family of proteins
35. Angiogenesis in cancer, vascular, rheumatoid and other disease
36. Seminars in medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
37. Angiogenic factors
38. Blood vessel formation: What is its molecular basis?
39. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion
40. Fibroblast growth factors and their receptors
41. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bd-2 and A1 in vascular endothelial cells
42. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart
43. Expression and control of vascular endothelial cells: Proliferation and differentiation by fibroblast growth factors
44. Structural characterization and biological functions of fibroblast growth factor
45. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro
46. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation
47. Vascular endothelial growth factor administration in chronic myocardial ischemia
48. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts
49. VEGF improves myocardial blood flow but produces EDRF-mediated hypotension in porcine hearts
50. Reduction ofischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia
51. Structure of platelet-derived growth factor: Implications for functional properties
52. Controlled delivery of vascular endothelial growth factor promotes neovascularization and maintains limb function in a rabbit model of ischemia
53. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor
54. Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb
55. Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein
56. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
57. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development
58. Vascular permeability factor, an endothelial cell mitogen related to PDGF
59. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolicacid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique
60. The fibroblast growth factor family: Structural and biological properties
61. Regulators of angiogenesis
62. Delivery strategies to achieve therapeutic myocardial angiogenesis
63. Angiogenesis factor from human myocardial infarcts
64. Intracoronary and intravenous administration of basic fibroblast growth factor: Myocardial and tissue distribution
65. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: Results of a phase I randomized, double-blind, placebo-controlled trial
66. Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty
67. Pharmacodynamics of basic fibroblast growth factor: Route of administration determines myocardial and systemic distribution
68. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: Effect on myocardial angiogenesis
69. Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121
70. Vascular endothelial growth factor is a secreted angiogenic mitogen
71. A cellular paradigm for the failure to increase vascular endothelial growth factor in chronically hypoxic states
72. An endothelial cell growth factor from the mouse neuroblastoma cell line NB41
73. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia
74. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion
75. A little VEGF goes a long way. Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA
76. Gene therapy on trial
77. Growth factors are released by mechanically wounded endothelial cells
78. Local delivery of r-hirudin by a double-balloon perfusion catheter prevents mural thrombosis and minimizes platelet deposition after angioplasty
79. Therapeutic angiogenesis induced by human recombinant hepatocyte growth factor in rabbit hind limb ischemia model as cytokine supplement therapy
80. VEGF165 expressed by a replication-deficient recombinant adenovirus vector induces angiogenesis in vivo
81. Mortality by cause for eight regions of the world: Global Burden of Disease Study
82. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
83. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
84. A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain
85. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
86. Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates
87. Manipulating angiogenesis. From basic science to the bedside
88. Transforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
89. Angiogenesis-regulating cytokines: Activities and interactions
90. Release from alginate enhances the biological activity of vascular endothelial growth factor
91. Vascular morphology and angiogenesis in glial tumors
92. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells
93. VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
94. The pathophysiology of angiogenesis
95. Differentiation of endothelium
96. Mechanisms of angiogenesis
97. Agedependent impairment of angiogenesis
98. Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF
99. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor
100. Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo
101. Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin
102. Sixmonth assessment of a phase I trial of angiogenic gene therapy for the treatment of coronary artery disease using direct intramyocardial administration of an adenovirus vector expressing the VEGF121 cDNA
103. Angiogenesis gene therapy: Phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease
104. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
105. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation
106. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF
107. Enhanced microvascular relaxations to VEGF and bFGF in chronically ischemic porcine myocardium
108. Molecular framework for angiogenesis: A complex web of interactions between extravasated plasma proteins and endothelial cell proteins induced by angiogenic cytokines
109. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
110. Expression of mRNA for vascular endothelial growth factor in human placenta
111. Structure and function of vascular endothelial growth factor receptor-1 and -2
112. Heparin affinity: Purification of a tumor-derived capillary endothelial cell growth factor
113. Involvement of the transcription factor NF-kappaB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress
114. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor
115. Basic fibroblast growth factor stimulates angiogenesis in the hindlimb of hyperglycemic rats
116. The anglogenins
117. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
118. Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease
119. Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischerma
120. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia
121. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo
122. Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia
123. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model
124. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
125. The clinical manipulation of angiogenesis: Pathology, sideeffects, surprises, and opportunities with novel human therapies
126. Angiopoietin-1 protects the adult vasculature against plasma leakage
127. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
128. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium
129. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
130. Basic fibroblast growth factor enhances myocardial collateral flow in a canine model
131. Differential control of VEGF synthesis and secretion in human glioma cells by IL-1 and EGF
132. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening
133. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor
134. Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase
135. Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia
136. Molecular cloning of a novel vascular endothelial growth factor, VEGF-D
137. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor
138. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis
139. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis
140. Surgical implications of therapeutic angiogenesis